[1]
A. SASIDHARAN, “IN SILICO EVALUATION OF CSF1R INHIBITORS: A PROMISING APPROACH FOR TARGETING NEUROINFLAMMATION IN NEURODEGENERATIVE DISEASES”, Int J App Pharm, vol. 17, no. 2, pp. 268–280, Mar. 2025.